Monte Rosa Therapeutics
GLUE
GLUE
68 hedge funds and large institutions have $272M invested in Monte Rosa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 10 closing their positions.
Holders
68
Holders Change
-1
Holders Change %
-1.45%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
33
Reduced
10
Closed
10
Calls
$511K
Puts
–
Net Calls
+$511K
Net Calls Change
-$83K
Top Buyers
1 |
BBA
1
Baker Bros. Advisors
New York
|
$20.7M |
2 |
ECM
2
ExodusPoint Capital Management
New York
|
$4.59M |
3 |
3
BlackRock
New York
|
$26.4M |
4 |
ACA
4
Avoro Capital Advisors
New York
|
$31.1M |
5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$26.7M |